342 related articles for article (PubMed ID: 20537899)
1. Sodium selenate specifically activates PP2A phosphatase, dephosphorylates tau and reverses memory deficits in an Alzheimer's disease model.
Corcoran NM; Martin D; Hutter-Paier B; Windisch M; Nguyen T; Nheu L; Sundstrom LE; Costello AJ; Hovens CM
J Clin Neurosci; 2010 Aug; 17(8):1025-33. PubMed ID: 20537899
[TBL] [Abstract][Full Text] [Related]
2. Over activation of hippocampal serine/threonine protein phosphatases PP1 and PP2A is involved in lead-induced deficits in learning and memory in young rats.
Rahman A; Khan KM; Al-Khaledi G; Khan I; Al-Shemary T
Neurotoxicology; 2012 Jun; 33(3):370-83. PubMed ID: 22387731
[TBL] [Abstract][Full Text] [Related]
3. Acetyl-L-carnitine attenuates okadaic acid induced tau hyperphosphorylation and spatial memory impairment in rats.
Yin YY; Liu H; Cong XB; Liu Z; Wang Q; Wang JZ; Zhu LQ
J Alzheimers Dis; 2010; 19(2):735-46. PubMed ID: 20110616
[TBL] [Abstract][Full Text] [Related]
4. Tau hyperphosphorylation correlates with reduced methylation of protein phosphatase 2A.
Zhou XW; Gustafsson JA; Tanila H; Bjorkdahl C; Liu R; Winblad B; Pei JJ
Neurobiol Dis; 2008 Sep; 31(3):386-94. PubMed ID: 18586097
[TBL] [Abstract][Full Text] [Related]
5. Sodium selenate mitigates tau pathology, neurodegeneration, and functional deficits in Alzheimer's disease models.
van Eersel J; Ke YD; Liu X; Delerue F; Kril JJ; Götz J; Ittner LM
Proc Natl Acad Sci U S A; 2010 Aug; 107(31):13888-93. PubMed ID: 20643941
[TBL] [Abstract][Full Text] [Related]
6. Targeting hyperphosphorylated tau with sodium selenate suppresses seizures in rodent models.
Jones NC; Nguyen T; Corcoran NM; Velakoulis D; Chen T; Grundy R; O'Brien TJ; Hovens CM
Neurobiol Dis; 2012 Mar; 45(3):897-901. PubMed ID: 22182692
[TBL] [Abstract][Full Text] [Related]
7. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.
Padmanabhan J; Levy M; Dickson DW; Potter H
Brain; 2006 Nov; 129(Pt 11):3020-34. PubMed ID: 16987932
[TBL] [Abstract][Full Text] [Related]
8. Substrate-specific reduction of PP2A activity exaggerates tau pathology.
Deters N; Ittner LM; Götz J
Biochem Biophys Res Commun; 2009 Feb; 379(2):400-5. PubMed ID: 19126401
[TBL] [Abstract][Full Text] [Related]
9. Nicotine exacerbates tau phosphorylation and cognitive impairment induced by amyloid-beta 25-35 in rats.
Deng J; Shen C; Wang YJ; Zhang M; Li J; Xu ZQ; Gao CY; Fang CQ; Zhou HD
Eur J Pharmacol; 2010 Jul; 637(1-3):83-8. PubMed ID: 20363218
[TBL] [Abstract][Full Text] [Related]
10. An aluminum-based rat model for Alzheimer's disease exhibits oxidative damage, inhibition of PP2A activity, hyperphosphorylated tau, and granulovacuolar degeneration.
Walton JR
J Inorg Biochem; 2007 Sep; 101(9):1275-84. PubMed ID: 17662457
[TBL] [Abstract][Full Text] [Related]
11. Contributions of protein phosphatases PP1, PP2A, PP2B and PP5 to the regulation of tau phosphorylation.
Liu F; Grundke-Iqbal I; Iqbal K; Gong CX
Eur J Neurosci; 2005 Oct; 22(8):1942-50. PubMed ID: 16262633
[TBL] [Abstract][Full Text] [Related]
12. Alzheimer's disease-like tau neuropathology leads to memory deficits and loss of functional synapses in a novel mutated tau transgenic mouse without any motor deficits.
Schindowski K; Bretteville A; Leroy K; Bégard S; Brion JP; Hamdane M; Buée L
Am J Pathol; 2006 Aug; 169(2):599-616. PubMed ID: 16877359
[TBL] [Abstract][Full Text] [Related]
13. Homocysteine induces tau phosphorylation by inactivating protein phosphatase 2A in rat hippocampus.
Zhang CE; Tian Q; Wei W; Peng JH; Liu GP; Zhou XW; Wang Q; Wang DW; Wang JZ
Neurobiol Aging; 2008 Nov; 29(11):1654-65. PubMed ID: 17537547
[TBL] [Abstract][Full Text] [Related]
14. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O
Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011
[TBL] [Abstract][Full Text] [Related]
15. Impaired spatial reference memory and increased exploratory behavior in P301L tau transgenic mice.
Pennanen L; Wolfer DP; Nitsch RM; Götz J
Genes Brain Behav; 2006 Jul; 5(5):369-79. PubMed ID: 16879631
[TBL] [Abstract][Full Text] [Related]
16. Amyloid-dependent triosephosphate isomerase nitrotyrosination induces glycation and tau fibrillation.
Guix FX; Ill-Raga G; Bravo R; Nakaya T; de Fabritiis G; Coma M; Miscione GP; Villà-Freixa J; Suzuki T; Fernàndez-Busquets X; Valverde MA; de Strooper B; Muñoz FJ
Brain; 2009 May; 132(Pt 5):1335-45. PubMed ID: 19251756
[TBL] [Abstract][Full Text] [Related]
17. Zinc induces protein phosphatase 2A inactivation and tau hyperphosphorylation through Src dependent PP2A (tyrosine 307) phosphorylation.
Xiong Y; Jing XP; Zhou XW; Wang XL; Yang Y; Sun XY; Qiu M; Cao FY; Lu YM; Liu R; Wang JZ
Neurobiol Aging; 2013 Mar; 34(3):745-56. PubMed ID: 22892311
[TBL] [Abstract][Full Text] [Related]
18. Methotrexate decreases PP2A methylation and increases tau phosphorylation in neuron.
Yoon SY; Choi HI; Choi JE; Sul CA; Choi JM; Kim DH
Biochem Biophys Res Commun; 2007 Nov; 363(3):811-6. PubMed ID: 17904102
[TBL] [Abstract][Full Text] [Related]
19. alpha7 Nicotinic receptor gene delivery into mouse hippocampal neurons leads to functional receptor expression, improved spatial memory-related performance, and tau hyperphosphorylation.
Ren K; Thinschmidt J; Liu J; Ai L; Papke RL; King MA; Hughes JA; Meyer EM
Neuroscience; 2007 Mar; 145(1):314-22. PubMed ID: 17218065
[TBL] [Abstract][Full Text] [Related]
20. Constitutive Dyrk1A is abnormally expressed in Alzheimer disease, Down syndrome, Pick disease, and related transgenic models.
Ferrer I; Barrachina M; Puig B; Martínez de Lagrán M; Martí E; Avila J; Dierssen M
Neurobiol Dis; 2005 Nov; 20(2):392-400. PubMed ID: 16242644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
